Press Releases

2010 | 2009 | 2008 | 2007 | 2006
Keyword Search
 
DateTitle
11/30/09Depomed Files Patent Infringement Lawsuit Against Lupin Limited
11/24/09Depomed to Present at Piper Jaffray's 21st Annual Health Care Conference
11/18/09Depomed Promotes William Callahan to Vice President of Operations
11/16/09Depomed Ranked #13 on Deloitte's Technology Fast 500TM
11/10/09Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA(R)
11/03/09Depomed to Present at Merriman Curhan Ford's Investor Summit 2009
10/29/09Depomed Reports Third Quarter 2009 Financial Results
10/22/09Depomed Announces Delivery of First Formulation to Covidien and Receipt of $500,000 Milestone Payment
10/22/09Depomed, Inc. to Announce Third Quarter 2009 Financial Results on October 29, 2009
10/12/09Depomed Reports Results From Two Phase 3 Clinical Trials Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
10/05/09Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia
09/09/09Depomed to Present at BioCentury's NewsMakers in the Biotech Industry Conference
09/02/09Depomed to Present at Rodman & Renshaw Annual Global Investment Conference
08/10/09Depomed Reports Encouraging Results of its Phase I Trial for DM-1992 Program in Parkinson's Disease
08/10/09Depomed to Present at Canaccord Adams' 29th Annual Global Growth Conference
07/30/09Depomed Reports Second Quarter 2009 Financial Results
07/23/09Depomed, Inc. to Announce Second Quarter 2009 Financial Results on July 30, 2009
07/22/09Depomed Provides License for Patents Covering Metformin Extended Release Technology to Merck & Co., Inc.
06/11/09Depomed to Present at Jefferies 3rd Annual Healthcare Conference
06/03/09Depomed to Present at Needham & Company's 8th Annual Life Sciences Conference
06/02/09Depomed Completes Enrollment of Phase 3 Clinical Program of DM-1796 in Post-Herpetic Neuralgia
06/01/09Depomed Names Shay Weisbrich Vice President of Marketing
05/19/09Depomed to Host Investor Day in New York City - RSVP Requested
05/15/09Depomed to Present at Deutsche Bank's 34th Annual Health Care Conference
05/04/09Depomed Reports First Quarter 2009 Financial Results
04/23/09Depomed, Inc. to Announce First Quarter 2009 Financial Results on May 4, 2009
04/02/09Depomed Completes Enrollment of Serada's Full Phase 3 Clinical Program in Menopausal Hot Flashes
03/10/09Depomed to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
03/05/09Depomed Reports Fourth Quarter and Year-End 2008 Financial Results
03/02/09Depomed Completes Enrollment of Breeze 1 Phase 3 Clinical Trial for Non-Hormonal Treatment in Menopausal Hot Flashes
02/19/09Depomed, Inc. to Announce Fourth Quarter and Year-End 2008 Financial Results on March 5, 2009
02/17/09Depomed Initiates Phase I Trial for DM-1992 Program in Parkinson's Disease Following Positive Results of Preclinical Studies Sponsored by The Michael J. Fox Foundation
02/03/09Depomed to Present at Upcoming Conferences
01/06/09Depomed's License Agreement With Solvay Pharmaceuticals Clears HSR Review
01/05/09Depomed Announces Management Promotions